Skybiotech Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Approval of Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Skybiotech Healthcare Ltd has informed BSE that its Board of Directors will meet on Saturday, 14 February 2026. The main agenda item is to consider and approve the unaudited financial results along with the limited review report for the quarter ended 31 December 2025 (Q3 FY26). The company, formerly known as Kapil Cotex Ltd, has filed this intimation under SEBI LODR Regulation 29(1)(a). No financial figures, forecasts, or business updates have been disclosed in this notice — only the meeting schedule and agenda.
This is a routine regulatory intimation and does not contain any new financial data, so it is unlikely to move the stock on its own. Investors should watch for the actual Q3 results announcement after 14 February 2026 for any meaningful business signals.